Cerebrolysin
Research use only.
High-purity research-grade Cerebrolysin
Cerebrolysin is a neuropeptide preparation extensively studied for its neuroprotective, neurotrophic, and cognitive-supportive properties. Derived from purified peptide fractions and amino acids, Cerebrolysin is commonly explored in neurological and cognitive research involving neurodegeneration, stroke recovery, traumatic brain injury, and age-related cognitive decline. Research interest primarily centers around its potential to support neuronal survival, synaptic plasticity, and brain repair mechanisms.
Product overview
Cerebrolysin is a peptide-based compound composed of low-molecular-weight neuropeptides and free amino acids designed to mimic the activity of endogenous neurotrophic factors. Preclinical and clinical research has associated Cerebrolysin with enhanced neuronal metabolism, reduced oxidative stress, and support for neuroregeneration in various neurological models. Its multifaceted mechanism has made it a widely investigated compound in cognitive and neurorehabilitation research.
Key research features
Supports cognitive function: Studies indicate Cerebrolysin may enhance memory formation, learning capacity, attention, and overall cognitive performance. These effects are believed to involve improved synaptic communication and support for neuronal plasticity.
Neuroprotective properties: Research suggests Cerebrolysin may help protect neurons from oxidative stress, excitotoxicity, and ischemic injury. Experimental models have demonstrated reduced neuronal damage and improved recovery outcomes following neurological stressors.
Neuroregenerative support: By influencing neurotrophic signaling pathways, Cerebrolysin has been investigated for its potential role in promoting neuronal repair, dendritic growth, and synaptic regeneration. This profile has generated significant interest in stroke and traumatic brain injury recovery research.
Research applications in neurodegenerative conditions: Early studies have explored the potential utility of Cerebrolysin in models involving Alzheimer’s disease, vascular dementia, Parkinsonian disorders, and age-related cognitive decline. Ongoing research continues to evaluate its broader role in long-term brain health and neurological resilience.
Cerebrolysin Suggested Use:
Typical Dose: 5–30 mL per day
Route: Intramuscular or intravenous injection
Frequency: Once daily
Duration: 10–20 days per cycle, or as recommended by a healthcare professional